75
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Pyruvate Kinase M2 regulates Hif-1α activity and IL-1β induction, and is a critical determinant of the Warburg Effect in LPS-activated macrophages

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          SUMMARY

          Macrophages activated by the TLR4 agonist LPS undergo dramatic changes in their metabolic activity. We here show that LPS induces expression of the key metabolic regulator Pyruvate Kinase M2 (PKM2). Activation of PKM2 using two well-characterized small molecules, DASA-58 and TEPP-46, inhibited LPS-induced Hif-1α and IL-1β, as well as the expression of a range of other Hif-1α-dependent genes. Activation of PKM2 attenuated an LPS-induced pro-inflammatory M1 macrophage phenotype while promoting traits typical of an M2 macrophage. We show that LPS-induced PKM2 enters into a complex with Hif-1α, which can directly bind to the IL-1β promoter, an event that is inhibited by activation of PKM2. Both compounds inhibited LPS- induced glycolytic reprogramming and succinate production. Finally, activation of PKM2 by TEPP-46 in vivo inhibited LPS and Salmonella typhimurium-induced IL-1β production, whilst boosting production of IL-10. PKM2 is therefore a critical determinant of macrophage activation by LPS, promoting the inflammatory response.

          Related collections

          Author and article information

          Journal
          101233170
          32527
          Cell Metab
          Cell Metab.
          Cell metabolism
          1550-4131
          1932-7420
          27 October 2016
          06 January 2015
          29 December 2016
          : 21
          : 1
          : 65-80
          Affiliations
          [1 ]School of Biochemistry and Immunology, Trinity Biomedical Science Institute, Trinity College Dublin, Dublin 2, Ireland
          [2 ]Centre for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA 02114, USA
          [3 ]Gastrointestinal Unit and Centre for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
          [4 ]Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA
          [5 ]Dept. of Clinical Medicine, School of Medicine, Trinity College, Dublin 2, Ireland
          [6 ]Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA02142, USA
          [7 ]National Institutes of Health (NIH), Chemical Genomics Centre, National Centre for Advancing Translational Sciences, NIH, Bethesda, MD20892, USA
          [8 ]Dana- Farber Cancer Institute, Harvard Medical School, Boston, MA02215, USA
          Author notes
          Corresponding Author: laoneill@ 123456tcd.ie (L.A.J. O’Neill), Telephone +353-1-896 2439, fax+ 353-1-677 2400
          Article
          PMC5198835 PMC5198835 5198835 nihpa825735
          10.1016/j.cmet.2014.12.005
          5198835
          25565206
          20952a59-127b-48f3-a2c9-4f189a6ef81c
          History
          Categories
          Article

          Comments

          Comment on this article